PhotoPharmics' Debt - III Round

PhotoPharmics raised a round of funding on March 07, 2017.

PhotoPharmics provides specialized phototherapy which allows dopamine to be assimilated by Parkinson's patients. A number of trials, including a 4-year, 130 patient study, demonstrate dramatic symptom…

Articles about PhotoPharmics' Debt - III Round: